𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts

✍ Scribed by P Munderi; AS Walker; C Kityo; AG Babiker; F Ssali; A Reid; JH Darbyshire; H Grosskurth; P Mugyenyi; DM Gibb; CF Gilks; on behalf of the DART/NORA trial teams


Book ID
111063688
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
272 KB
Volume
11
Category
Article
ISSN
1464-2662

No coin nor oath required. For personal study only.